Caribou Biosciences, Inc.CRBUNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-112.35M
↓ 40% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-80.35M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-112.35M | +22.4% |
| 2024 | $-144.71M | -37.9% |
| 2023 | $-104.90M | -7.7% |
| 2022 | $-97.42M | -173.3% |
| 2021 | $-35.64M | -3.2% |
| 2020 | $-34.53M | -5.0% |
| 2019 | $-32.89M | - |